Minghao Luo
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Inflammasome and immune disorders 8
-
- Atherosclerosis and Cardiovascular Diseases 3
- Co-authors
- Suxin Luo (21 shared papers)Dingyi Lv (22 shared papers)Yongzheng Guo (11 shared papers)Longxiang Huang (14 shared papers)Jianghong Yan (10 shared papers)Zhe Cheng (9 shared papers)Guo-wei Tu (18 shared papers)Jing‐chao Luo (17 shared papers)
- Journals
- Heliyon (5 papers)International Immunopharmacology (3 papers)Biochemical and Biophysical Research Communications (2 papers)Journal of Molecular Graphics and Modelling (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Minghao Luo
68 papers receiving 994 citations
Peers
Comparison fields: 5 of 116
- Geriatrics and Gerontology 42
- Biological Psychiatry 18
- Biochemistry 42
- Immunology 141
- Nephrology 47
Countries citing papers authored by Minghao Luo
This map shows the geographic impact of Minghao Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghao Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghao Luo more than expected).
Fields of papers citing papers by Minghao Luo
This network shows the impact of papers produced by Minghao Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghao Luo. The network helps show where Minghao Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Minghao Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 68 | |
| 2 | 2021 | 67 | |
| 3 | 2022 | 60 | |
| 4 | 1997 | 49 | |
| 5 | 2022 | 47 | |
| 6 | 2021 | 32 | |
| 7 | 2020 | 31 | |
| 8 | 2022 | 31 | |
| 9 | 2022 | 29 | |
| 10 | 2021 | 28 | |
| 11 | 2022 | 28 | |
| 12 | 2020 | 27 | |
| 13 | 2021 | 25 | |
| 14 | 2021 | 25 | |
| 15 | 2021 | 22 | |
| 16 | 2020 | 22 | |
| 17 | 2021 | 21 | |
| 18 | 2017 | 20 | |
| 19 | 2021 | 19 | |
| 20 | 2020 | 18 |
About Minghao Luo
Minghao Luo is a scholar working on Molecular Biology, Immunology, Physiology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 70 papers that have together received 1.0k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (8 papers), Nitric Oxide and Endothelin Effects (5 papers), Lipid metabolism and disorders (4 papers), Aortic Disease and Treatment Approaches (4 papers), Adipose Tissue and Metabolism (4 papers), Cancer-related molecular mechanisms research (3 papers), Traditional Chinese Medicine Analysis (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). The work is most often cited by research in Geriatrics and Gerontology (42 citations), Biological Psychiatry (18 citations), Biochemistry (42 citations), Immunology (141 citations) and Nephrology (47 citations). Minghao Luo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Suxin Luo, Dingyi Lv, Yongzheng Guo, Longxiang Huang, Jianghong Yan, Zhe Cheng, Guo-wei Tu, Jing‐chao Luo, Zhe Luo and Fei‐Fei Shang. Their work appears in journals such as Heliyon, International Immunopharmacology, Biochemical and Biophysical Research Communications, Journal of Molecular Graphics and Modelling and Oxidative Medicine and Cellular Longevity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.